Abstract| Volume 18, ISSUE 6, SUPPLEMENT , S10, June 2016

The Role of Consumer Protection Law in Addressing the Marketing of Stem Cell Therapies

      The growing number of clinics marketing stem cell therapies that are inadequately supported by evidence of safety and efficacy is a matter of ongoing concern. Researchers and scientific societies (notably ISCT) have worked to raise awareness and regulatory agencies have taken action in some cases, yet the proliferation of clinics continues. Some have suggested using consumer protection laws as another potential tool, focusing on the claims that clinics make in marketing their services. Most jurisdictions have laws that prohibit false or deceptive advertising, and this could provide a mechanism by which to hold clinics accountable and prevent patients from being induced to spend significant sums of money and put themselves at risk to try treatments that have little or no benefit and may be harmful.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect